English
  1. Home
  2. Stocks
  3. Windlas Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Windlas Biotech

    Small Cap
    ₹717.65
    +24 (3.46%)
    01 July, 2024 06:43 BSE: 543329 NSE: WINDLASISIN: INE0H5O01029

    Start SIP in Windlas Biotech

    Start SIP

    Windlas Biotech Performance

    Day Range

    • Low 690
    • High 723
    ₹ 717

    52 Week Range

    • Low 296
    • High 795
    ₹ 717
    • Open Price697
    • Previous Close694
    • Volume51385

    Windlas Biotech Share Price

    • Over 1 Month +14.92%
    • Over 3 Month +40.63%
    • Over 6 Month +67.38%
    • Over 1 Year +134.99%

    Windlas Biotech Key Statistics

    P/E Ratio 25.8
    PEG Ratio 0.7
    Market Cap Cr 1,500
    Price to Book Ratio 3.3
    EPS 27.8
    Dividend 0.6
    Relative Strength Index 65.52
    Money Flow Index 74.76
    MACD Signal 33.42
    Average True Range 30.57
    Windlas Biotech Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 171162153145141
    Operating Expenses Qtr Cr 149142134128124
    Operating Profit Qtr Cr 2220191716
    Depreciation Qtr Cr 43334
    Interest Qtr Cr 00000
    Tax Qtr Cr 65444
    Net Profit Qtr Cr 1715141211
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 644523
    Operating Expenses Annual Cr 553453
    Operating Profit Annual in Cr 7860
    Depreciation Cr 1312
    Interest Annual Cr 11
    Tax Annual Cr 1914
    Net Profit Annual Cr 5843
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 10961
    Cash from Investing Activity Annual Cr -92-14
    Cash from Financing Annual Activity Cr -15-44
    Net Cash Flow Annual Cr 3
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 450403
    Fixed Assets Annual Cr 185124
    Total Non Current Assets Annual Cr 195175
    Total Current Assets Annual Cr 431354
    Total Assets Annual Cr 626529
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 217192
    ROE Annual % 1311
    ROCE Annual % 1714
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1514
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 171162153145141
    Operating Expenses Qtr Cr 149142134128124
    Operating Profit Qtr Cr 2220191716
    Depreciation Qtr Cr 43334
    Interest Qtr Cr 00000
    Tax Qtr Cr 65444
    Net Profit Qtr Cr 1715141211
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 644523
    Operating Expenses Annual Cr 553453
    Operating Profit Annual in Cr 7860
    Depreciation Cr 1312
    Interest Annual Cr 11
    Tax Annual Cr 1914
    Net Profit Annual Cr 5843
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 10961
    Cash from Investing Activity Annual Cr -92-14
    Cash from Financing Annual Activity Cr -15-44
    Net Cash Flow Annual Cr 3
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 450402
    Fixed Assets Annual Cr 185124
    Total Non Current Assets Annual Cr 195175
    Total Current Assets Annual Cr 431354
    Total Assets Annual Cr 626529
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 216192
    ROE Annual % 1311
    ROCE Annual % 1714
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1514
    Invest in Windlas Biotech

    Windlas Biotech Technicals

    EMA & SMA

    Current Price
    ₹717.65
    +24 (3.46%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹683.18
    • 50 Day
    • ₹630.03
    • 100 Day
    • ₹577.24
    • 200 Day
    • ₹507.27
    • 20 Day
    • ₹684.66
    • 50 Day
    • ₹610.33
    • 100 Day
    • ₹567.18
    • 200 Day
    • ₹487.92

    Windlas Biotech Resistance and Support

    PIVOT
    ₹710.27
    Resistance
    First Resistance 730.48
    Second Resistance 743.32
    Third Resistance 763.53
    RSI 65.52
    MFI 74.76
    MACD Single Line 33.42
    MACD 30.32
    Support
    First Support 697.43
    Second Support 677.22
    Third Supoort 664.38

    Windlas Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 58,109 2,882,206 49.6
    Week 40,042 2,113,406 52.78
    1 Month 99,934 4,998,706 50.02
    6 Month 166,292 6,066,314 36.48

    Windlas Biotech Result Highlights

    Windlas Biotech Synopsis

    NSE-Medical-Ethical Drugs

    Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 513.08 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
    Market Cap 1,500
    Sales 631
    Shares in Float 0.77
    No of funds 15
    Yield 0.74
    Book Value 3.31
    U/D Vol ratio 1.9
    LTDebt / Equity
    Alpha 0.2
    Beta 1.02

    Windlas Biotech Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 62.82%62.82%62.82%62.82%
    Mutual Funds 10.37%10.4%10.43%10.51%
    Foreign Portfolio Investors 1.18%1.35%0.8%0.8%
    Financial Institutions/ Banks 0.04%0.04%0.04%
    Individual Investors 21.19%21.21%21.63%22.01%
    Others 4.44%4.18%4.28%3.82%

    Windlas Biotech Management

    Name Designation
    Mr. Vivek Dhariwal Chairman & Ind.Director
    Mr. Hitesh Windlass Managing Director
    Mr. Manoj Kumar Windlass Joint Managing Director
    Mr. Pawan Kumar Sharma Executive Director
    Mr. Ashok Kumar Windlass Whole Time Director
    Mrs. Prachi Jain Windlass Non Executive Director
    Mr. Srinivasan Venkataraman Ind. Non-Executive Director
    Mr. Gaurav Gulati Ind. Non-Executive Director

    Windlas Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Windlas Biotech Corporate Action

    Date Purpose Remarks
    2024-05-20 Audited Results & Dividend
    2024-02-08 Quarterly Results
    2023-11-08 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-05 Audited Results & Final Dividend

    Windlas Biotech MF Shareholding

    Name Amount(cr)
    ICICI Prudential Smallcap Fund Growth 7,795
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,925
    UTI Healthcare Fund Regular Plan Growth 938

    Windlas Biotech FAQs

    What is Share Price of Windlas Biotech ?

    Windlas Biotech share price is ₹717 As on 01 July, 2024 | 06:29

    What is the Market Cap of Windlas Biotech ?

    The Market Cap of Windlas Biotech is ₹1499.9 Cr As on 01 July, 2024 | 06:29

    What is the P/E ratio of Windlas Biotech ?

    The P/E ratio of Windlas Biotech is 25.8 As on 01 July, 2024 | 06:29

    What is the PB ratio of Windlas Biotech ?

    The PB ratio of Windlas Biotech is 3.3 As on 01 July, 2024 | 06:29

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.